CRSP Market Cap History
Below is a table of the CRSP market cap history going back to 10/19/2016:

Date CRSP Market Cap
10/19/2016560.05M
11/21/2016828.02M
3/1/2017894.53M
5/8/2017667.96M
8/7/2017750.95M
11/3/2017781.42M
2/28/20182.28B
4/30/20182.21B
8/1/20182.30B
11/1/20181.85B
2/21/20191.63B
4/25/20192.09B
7/25/20192.71B

Also see: CRSP Shares Outstanding History
and CRSP YTD Return
CRSP Historical Market Cap:
+77.00% CAGR
CRSP Historical Market Cap: +77.00% CAGR

Mouse over chart for data details
10/19/2016 ...7/25/2019
CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9). CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is also progressing several gene-edited allogeneic cell therapy programs. Co.'s product candidate, CTX001™, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia and severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. We show 13 historical shares outstanding datapoints in our CRSP shares outstanding history coverage, used to compute CRSP market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CRSP market cap history over the course of time is important for investors interested in comparing CRSP's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CRSP versus a peer is one thing; comparing CRSP market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CRSP can fluctuate over the course of history. With this page we aim to empower investors researching CRSP by allowing them to research the CRSP market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for CRSP:
CRSP SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
CRISPR Therapeutics AG (CRSP) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CRWD Market Cap History
CSML Market Cap History
CTAC Market Cap History
CTRA Market Cap History
CTRC Market Cap History
CTVA Market Cap History
CUE Market Cap History
CVET Market Cap History
CVIA Market Cap History
CVON Market Cap History
More Miscellaneous companies »

 

CRSP Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.